Beautiful Virgin Islands


After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine

After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine

Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have eroded confidence.
*Your email address will not be displayed on website
This article does not have any comments yet.
Beautiful Virgin Islands
0:00
0:00
Close
×